RADIATION · Unmapped registry intervention
High dose rate prostate brachytherapy
Find medicine records ·
Find other trials using this name
Clinical trial
Multi-omic Approach to Study HDR Brachytherapy for Favorable Risk and Low Tier Intermediate Risk Prostate Cancer
NCT06200974
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedMulti-omic Approach to Study HDR Brachytherapy for Favorable Risk and Low Tier Intermediate Risk Prostate Cancer
Design: OBSERVATIONAL · Status: RECRUITING · Phase: Not specified
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Localized Prostate Carcinomaunresolved
Interventions
Sponsors & collaborators
British Columbia Cancer Agencylead sponsor
BC Cancer Foundationcollaborator
University of British Columbiacollaborator
Vancouver Prostate Centrecollaborator
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06200974 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.